Evidence map›Paper›PMID 28572264›Full record

ReviewClinical cancer research : an official journal of the American Association for Cancer Research2017

Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders.

Michael F Walsh, Vivian Y Chang, Wendy K Kohlmann, Hamish S Scott, Christopher Cunniff, Franck Bourdeaut, Jan J Molenaar, Christopher C Porter, John T Sandlund, Sharon E Plon and 2 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical cancer research : an official journal of the American Association for Cancer Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 115 citations in OpenAlex.

  1. Cancer Effects of Low to Moderate Doses of Ionizing Radiation in Young People with Cancer-Predisposing Conditions: A Systematic Review.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Pediatric Cancer Predisposition and Surveillance Update: Summary Perspective and Future Directions.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Biallelic GermlineInternational journal of molecular sciences · 2024
    Article
  11. Update on Recommendations for Cancer Screening and Surveillance in Children with Genomic Instability Disorders.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Clinical manifestations of telomere biology disorders in adults.Hematology. American Society of Hematology. Education Program · 2023
    Review
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Michael F WalshMemorial Sloan Kettering Cancer Center, New York, New York. walshm2@mskcc.org savagesh@mail.nih.gov.
Vivian Y ChangUniversity of California, Los Angeles, Los Angeles, California.
Wendy K KohlmannHuntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Hamish S ScottDepartment of Genetics and Molecular Pathology, Centre for Cancer Biology, Adelaide, South Australia.
Christopher CunniffWeill Cornell Medical College, New York, New York.
Franck BourdeautInstitut Curie, Integrated Cancer Research Site, Paris, France.
Jan J MolenaarPrincess Máxima Center for Pediatric Oncology, Amsterdam, the Netherlands.
Christopher C PorterEmory University, Atlanta, Georgia.
John T SandlundSt. Jude Children's Research Hospital, Memphis, Tennessee.
Sharon E PlonBaylor College of Medicine, Texas Children's Hospital, Houston, Texas.
Lisa L WangBaylor College of Medicine, Texas Children's Hospital, Houston, Texas.
Sharon A SavageNational Cancer Institute, Rockville, Maryland. walshm2@mskcc.org savagesh@mail.nih.gov.
Huntsman Cancer Institute · USKettering University · USUniversity of California, Los Angeles · US

Funding

Clinical Genetic Studies of Familial and Hereditary Cancer SyndromesZIACP010144 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SAVAGE, SHARON A. · 2009 to 2025
$111.8M
Clinical and Translational Science CenterUL1TR000457 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$46.0M
Intramural NIH HHS ZIA CP010144NCATS NIH HHS UL1 TR000457
6 · The paper itself

Abstract

DNA repair syndromes are heterogeneous disorders caused by pathogenic variants in genes encoding proteins key in DNA replication and/or the cellular response to DNA damage. The majority of these syndromes are inherited in an autosomal-recessive manner, but autosomal-dominant and X-linked recessive disorders also exist. The clinical features of patients with DNA repair syndromes are highly varied and dependent on the underlying genetic cause. Notably, all patients have elevated risks of syndrome-associated cancers, and many of these cancers present in childhood. Although it is clear that the risk of cancer is increased, there are limited data defining the true incidence of cancer and almost no evidence-based approaches to cancer surveillance in patients with DNA repair disorders. This article is the product of the October 2016 AACR Childhood Cancer Predisposition Workshop, which brought together experts from around the world to discuss and develop cancer surveillance guidelines for children with cancer-prone disorders. Herein, we focus on the more common of the rare DNA repair disorders: ataxia telangiectasia, Bloom syndrome, Fanconi anemia, dyskeratosis congenita, Nijmegen breakage syndrome, Rothmund-Thomson syndrome, and Xeroderma pigmentosum. Dedicated syndrome registries and a combination of basic science and clinical research have led to important insights into the underlying biology of these disorders. Given the rarity of these disorders, it is recommended that centralized centers of excellence be involved directly or through consultation in caring for patients with heritable DNA repair syndromes.

Indexed as

Early Detection of CancerAtaxia TelangiectasiaBloom SyndromeChildDNA RepairDNA Repair-Deficiency DisordersFanconi AnemiaHumansNeoplasmsXeroderma Pigmentosum

Identifiers

PMID28572264
PMCPMC5697784
OpenAlexW2620893947

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.